Literature DB >> 9428486

Chondrosarcoma of the larynx: the role of radiotherapy revisited--a case report and review of the literature.

S Gripp1, H Pape, G Schmitt.   

Abstract

BACKGROUND: Experience in the treatment of laryngeal chondrosarcoma is based on about 250 cases reported to date. The standard therapy is conservative surgery. Radiotherapy has universally been regarded as ineffective in the treatment of this disease.
METHODS: A patient with a laryngeal chondrosarcoma was observed for 11 years after radical radiotherapy. The literature on laryngeal chondrosarcoma was critically reviewed, with emphasis placed on radiotherapy.
RESULTS: The review of the literature revealed that experience with radiotherapy of laryngeal chondrosarcoma has been lacking, with fewer than 10 cases with short follow-up documented up to now. Meanwhile, increasing evidence of the efficacy of radiotherapy in the treatment of skeletal chondrosarcoma has emerged. The authors report the first case of chondrosarcoma of the larynx in which radical radiotherapy resulted in a long term remission of more than 10 years.
CONCLUSIONS: Radiotherapy should be considered when radical surgery is not feasible without severe mutilation. It should also be considered for the treatment of residual disease. Laryngectomy should be restricted to salvage treatment when radiotherapy fails. In this study, radiotherapy appeared to be an effective modality in the treatment of low grade laryngeal chondrosarcoma, and these results contrast with the current widespread disapproval of this treatment.

Entities:  

Mesh:

Year:  1998        PMID: 9428486     DOI: 10.1002/(sici)1097-0142(19980101)82:1<108::aid-cncr13>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  13 in total

1.  [Surgical extirpation. The therapy of choice for chondrosarcoma of the larynx].

Authors:  R Krempien
Journal:  HNO       Date:  2011-04       Impact factor: 1.284

2.  [Chondrosarcoma of the larynx. Experience gained in Freiburg since 1999].

Authors:  C C Boedeker; W Maier; M Boedeker; G J Ridder; T Klenzner; G Kayser; C Offergeld
Journal:  HNO       Date:  2011-04       Impact factor: 1.284

Review 3.  Tracheal chondrosarcoma.

Authors:  Vera Mendonça; Marília Jorge; Isabel Monteiro-Grillo; Maria João Palhano; Salvato Feijó
Journal:  Clin Transl Oncol       Date:  2010-08       Impact factor: 3.405

Review 4.  Chondrosarcomas of the head and neck.

Authors:  Andrés Coca-Pelaz; Juan P Rodrigo; Asterios Triantafyllou; Jennifer L Hunt; Juan C Fernández-Miranda; Primož Strojan; Remco de Bree; Alessandra Rinaldo; Robert P Takes; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-10       Impact factor: 2.503

5.  Chondrosarcoma of the larynx: a case report.

Authors:  M Policarpo; F Taranto; E Aina; P Valletti Aluffi; F Pia
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-02       Impact factor: 2.124

6.  Well and intermediate differentiated laryngeal chondrosarcoma: toward conservative surgery?

Authors:  Valerio Damiani; Erika Crosetti; Giuseppe Rizzotto; Angelo Camaioni; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-08-23       Impact factor: 2.503

7.  The radiation response of sarcomas by histologic subtypes: a review with special emphasis given to results achieved with razoxane.

Authors:  Walter Rhomberg
Journal:  Sarcoma       Date:  2006

8.  Tracheal Chondrosarcoma: Systematic Review of Tumor Characteristics, Diagnosis, and Treatment Outcomes with Case Report.

Authors:  Emily A Kutzner; Joshua S Park; Salman Zaheer; Jared C Inman
Journal:  Case Rep Oncol Med       Date:  2017-05-23

9.  Laryngeal Chondrosarcoma: an Exceptional Localisation of a not Unfrequent Bone Tumor.

Authors:  Mieke Moerman; Bernard Kreps; Ramses Forsyth
Journal:  Sarcoma       Date:  2009-12-29

10.  Laryngeal chondrosarcoma as a rare cause of subglottic stenosis.

Authors:  Kerem Kökoğlu; Ozlem Canöz; Serap Doğan; Emrah Gülmez; Imdat Yüce; Sedat Cağlı
Journal:  Case Rep Otolaryngol       Date:  2014-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.